Allergan shares jump after Morgan Stanley says fears of a 'better Botox' are overdone
November 29, 2017 at 08:47 AM EST
"If we are correct, … AGN shares could benefit," Morgan Stanley analyst David Risinger says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.